Author | David Frabotta


FDA Approves New COPD Maintenance Treatment

April 24, 2019

DUAKLIR PRESSAIR (aclidinium bromide and formoterol fumarate) provides LAMA/LABA therapy.

EPA’s New Rules on Drug Disposal Begin in August

April 17, 2019

Approved regulations allow for some flexibility for drugs that can be redistributed or qualify for manufacturer credit. 

Balversa Fast-Tracked for Bladder Cancer

April 12, 2019

Erdafitinib is first targeted therapy for FGFR3 or FGFR2 genetic alteration.

BD Unveils New Tool to Fight Opioid Crisis

December 17, 2018

Health systems employ Artifical Intelligence and integrated medication management to address diversion.